Literature DB >> 24595121

Laser treatment of benign prostate enlargement--which laser for which prostate?

Malte Rieken1, Alexander Bachmann1.   

Abstract

Laser-based prostatectomy for benign prostatic obstruction has emerged over the past decade as a treatment alternative to transurethral resection of the prostate (TURP) and open prostatectomy. These techniques set new standards in minimally invasive surgery and aim to obviate the complications of open surgery while ensuring durability of outcomes. Enucleation, which mimics open prostatectomy in that the whole prostate adenoma is removed, and vaporization, which involves ultra-rapid heating of superficial tissue layers and subsequent ablation, are the most often used surgical techniques in laser prostatectomy. The wavelength and the power output of the laser influence the tissue-laser interactions, which determine the physical properties and the safety profile of the technique. Holmium laser enucleation of the prostate (HoLEP) and GreenLight(™) laser vaporization of the prostate are the two reference techniques for laser prostatectomy, both of which have been shown to be as effective as TURP, while offering advantages in the safety profile in various randomized trials. Thulium laser enucleation of the prostate (ThuLEP) shares similarities with HoLEP and has shown encouraging results. However, more controlled trials with longer follow-up assessment are needed. Diode lasers come in various wavelengths and fibre designs and have been used for vaporization and enucleation, but require high-quality data to support their clinical use.

Entities:  

Mesh:

Year:  2014        PMID: 24595121     DOI: 10.1038/nrurol.2014.23

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  88 in total

1.  [Benign prostate hyperplasia].

Authors:  U Jonas; A I Gabouev; T R W Herrmann; K Höfner; M C Michel; M Alschibaja; R Hartung
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

2.  Holmium laser enucleation versus bipolar resection of the prostate: a prospective randomized study. Which to choose?

Authors:  Amr S Fayad; Mohamed G El Sheikh; Tamer Zakaria; Hazem A Elfottoh; Rageb Alsergany
Journal:  J Endourol       Date:  2011-07-11       Impact factor: 2.942

3.  GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up.

Authors:  Carlos Capitán; Cristina Blázquez; M Dolores Martin; Virginia Hernández; Enrique de la Peña; Carlos Llorente
Journal:  Eur Urol       Date:  2011-06-01       Impact factor: 20.096

4.  Three-year outcome following holmium laser enucleation of the prostate combined with mechanical morcellation in 330 consecutive patients.

Authors:  Ivano Vavassori; Sergio Valenti; Richard Naspro; Alberto Vismara; Vincenzo Dell'Acqua; Alberto Manzetti; Rodolfo Hurle
Journal:  Eur Urol       Date:  2007-11-05       Impact factor: 20.096

5.  High power diode laser vaporization of the prostate: preliminary results for benign prostatic hyperplasia.

Authors:  Ali Erol; Kamil Cam; Ali Tekin; Omur Memik; Soner Coban; Yavuz Ozer
Journal:  J Urol       Date:  2009-07-18       Impact factor: 7.450

6.  A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).

Authors:  A H H Tan; P J Gilling; K M Kennett; C Frampton; A M Westenberg; M R Fraundorfer
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

7.  Mid term outcomes of initial 250 case experience with GreenLight 120W-HPS photoselective vaporization prostatectomy for benign prostatic hyperplasia: comparison of prostate volumes < 60 cc, 60 cc-100 cc and > 100 cc.

Authors:  Pierre-Alain Hueber; Tal Ben-Zvi; Daniel Liberman; Naeem Bhojani; Gagan Gautam; Tom Deklaj; Mark Katz; Kevin C Zorn
Journal:  Can J Urol       Date:  2012-10       Impact factor: 1.344

8.  Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas >80ml: 12-mo results of a randomized prospective study.

Authors:  Gerasimos Alivizatos; Andreas Skolarikos; Dimitrios Chalikopoulos; Christos Papachristou; Odysseas Sopilidis; Athanasios Dellis; Ioannis Kastriotis; Charalambos Deliveliotis
Journal:  Eur Urol       Date:  2007-11-29       Impact factor: 20.096

9.  Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center prospective randomized trial in patients with obstructive benign prostatic hyperplasia.

Authors:  Francesco Montorsi; Richard Naspro; Andrea Salonia; Nazareno Suardi; Alberto Briganti; Matteo Zanoni; Sergio Valenti; Ivano Vavassori; Patrizio Rigatti
Journal:  J Urol       Date:  2008-05       Impact factor: 7.450

10.  The diode laser: a novel side-firing approach for laser vaporisation of the human prostate--immediate efficacy and 1-year follow-up.

Authors:  Michael Seitz; Ronald Sroka; Christian Gratzke; Boris Schlenker; Verena Steinbrecher; Wael Khoder; Derya Tilki; Alexander Bachmann; Christian Stief; Oliver Reich
Journal:  Eur Urol       Date:  2007-06-26       Impact factor: 20.096

View more
  17 in total

Review 1.  Update on Greenlight laser vaporization (PVP) 2014.

Authors:  Malte Rieken; Alexander Bachmann
Journal:  World J Urol       Date:  2014-11-05       Impact factor: 4.226

2.  Benign prostatic hyperplasia surgical scoring (BPHSS): an novel scoring system for the perioperative outcomes of holmium laser enucleation of the prostate.

Authors:  Huan Xu; Zhikang Cai; Yanbo Chen; Meng Gu; Qi Chen; Zhong Wang
Journal:  Lasers Med Sci       Date:  2018-01-08       Impact factor: 3.161

Review 3.  Update on the use of diode laser in the management of benign prostate obstruction in 2014.

Authors:  Lukas Lusuardi; Michael Mitterberger; Stephan Hruby; Thomas Kunit; Birgit Kloss; Paul F Engelhardt; Manuela Sieberer; Günter Janetschek
Journal:  World J Urol       Date:  2014-05-24       Impact factor: 4.226

4.  Randomized, controlled trial of laser vs. bipolar plasma vaporization treatment of benign prostatic hyperplasia.

Authors:  Thomas A A Skinner; Robert J Leslie; Stephen S Steele; J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2017-06       Impact factor: 1.862

5.  The 80-W KTP GreenLight laser vaporization of the prostate versus transurethral resection of the prostate (TURP): adjusted analysis of 5-year results of a prospective non-randomized bi-center study.

Authors:  Sanwei Guo; Georg Müller; Kurt Lehmann; Scherwin Talimi; Gernot Bonkat; Heike Püschel; Thomas Gasser; Alexander Bachmann; Malte Rieken
Journal:  Lasers Med Sci       Date:  2015-02-20       Impact factor: 3.161

Review 6.  Thulium Fiber Laser Behavior on Tissue During Upper- and Lower-Tract Endourology.

Authors:  Vasileios Gkolezakis; Patrick Rice; Bhaskar Kumar Somani; Theodoros Tokas
Journal:  Curr Urol Rep       Date:  2022-09-30       Impact factor: 2.862

7.  The effectiveness and safety of three surgical procedures for the treatment for benign prostatic hyperplasia: A network meta-analysis.

Authors:  Jiusong Yan; Liang Gao; Guangyong Xu; Junyong Zhang
Journal:  Heliyon       Date:  2022-10-04

Review 8.  GreenLight Laser™ Photovaporization versus Transurethral Resection of the Prostate: A Systematic Review and Meta-Analysis.

Authors:  Daniele Castellani; Giacomo Maria Pirola; Emanuele Rubilotta; Marilena Gubbiotti; Simone Scarcella; Martina Maggi; Vineet Gauhar; Jeremy Yuen-Chun Teoh; Andrea Benedetto Galosi
Journal:  Res Rep Urol       Date:  2021-05-20

9.  Different lasers in the treatment of benign prostatic hyperplasia: a network meta-analysis.

Authors:  Xingming Zhang; Pengfei Shen; Qiying He; Xiaoxue Yin; Zhibin Chen; Haojun Gui; Kunpeng Shu; Qidun Tang; Yaojing Yang; Xiuyi Pan; Jia Wang; Ni Chen; Hao Zeng
Journal:  Sci Rep       Date:  2016-03-24       Impact factor: 4.379

10.  5-year long-term efficacy of 120-W GreenLight photoselective vaporization of the prostate for benign prostate hyperplasia.

Authors:  Juhyun Park; Sung Yong Cho; Min Chul Cho; Hyeon Jeong; Hwancheol Son
Journal:  PLoS One       Date:  2017-09-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.